Select Stabilization of a Tumor-Suppressive PP2A Heterotrimer

Vidhi M Shah1, Isabel A English2, Rosalie C Sears3

  • 1Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR, USA; Brenden Colson Center for Pancreatic Care, Oregon Health and Science University, Portland, OR, USA.

Insights

A new activator, DT-061, stabilizes protein phosphatase 2A (PP2A) to counteract cancer signaling. Structural insights into PP2A offer new avenues for developing phosphatase therapeutics.

Area of Science:

  • Oncology
  • Biochemistry
  • Structural Biology

Background:

  • Aberrant signaling in cancer often involves the suppression of protein phosphatases, like protein phosphatase 2A (PP2A).
  • PP2A counteracts kinase activity, and its suppression contributes to uncontrolled cell growth and oncogenesis.

Purpose of the Study:

  • To investigate the potential of small molecules to reactivate suppressed PP2A in cancer.
  • To characterize the structural basis for PP2A activation by a novel compound.

Main Methods:

  • Utilized cryo-electron microscopy (cryo-EM) to determine the structure of a PP2A heterotrimer assembly.
  • Employed a novel small-molecule activator, DT-061, to target and stabilize specific PP2A holoenzymes.

Main Results:

  • DT-061 selectively stabilizes a PP2A holoenzyme crucial for dephosphorylating oncogenic targets, including MYC.
  • A 3.6-Å cryo-EM map revealed the druggable structure of the activated PP2A heterotrimer.

Conclusions:

  • DT-061 demonstrates potential as a therapeutic agent by restoring PP2A function in cancer.
  • The structural information provides a foundation for designing future phosphatase-based cancer therapeutics.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated...
5.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.2K